article thumbnail

Stabilising Europe’s generic medicine supply

European Pharmaceutical Review

For instance, in the EU, 46 percent of generic medicines from the EU Critical List of Medicines are provided by a single supplier. For these firms with over 60 percent market share, this number rises to 83 percent of critical generic medicines, according to the data.

article thumbnail

How could tariffs impact the pharmaceutical industry?

European Pharmaceutical Review

The US imports a substantial volume of APIs and finished medicines, many of which are essential for patient care, meaning these tariffs could have far-reaching implications. 1 Here, we explore the potential impact of tariffs on pharmaceutical supply chains, pricing, investment and industry strategy.